Juil 10, 2023
News & partners
Dianosic is a biotech focused on the development of novel solutions integrated drug and
delivery system for the localized treatment of patients with chronic rhinitis and chronic rhinosinusitis.
Latest news
Mar 31, 2021
Challenges – Dianosic a été sélectionnée parmi les 100 startups les plus innovantes où investir en 2021 !
See more
Our investors
We built a solid network of partners to support company funding and growth.
Fondation Force
Bpi France
Banque Populaire Rives de Paris
Caisse d’épargne Grand Est
Wiseed
